Said Sebti

Protein farnesyltransferase inhibitors exhibit potent antimalarial activity.

David K Williams, Patricia C Weber, D. Chakrabarti, 2005, Journal of medicinal chemistry.

Identification of compounds that enhance the anti-lymphoma activity of rituximab using flow cytometric high-content screening.

Perry Haaland, P. Haaland, K. Bhalla, 2004, Journal of immunological methods.

Rb–Raf-1 Interaction Disruptor RRD-251 Induces Apoptosis in Metastatic Melanoma Cells and Synergizes with Dacarbazine

Sandeep Singh, S. Sebti, S. Chellappan, 2010, Molecular Cancer Therapeutics.

Randomized, Placebo-Controlled Trial of Green Tea Catechins for Prostate Cancer Prevention

Michael J. Schell, Ganna Chornokur, Mohamed Helal, 2015, Cancer Prevention Research.

Structure-based Design of High Affinity Peptides Inhibiting the Interaction of p53 with MDM2 and MDMX*

Ernst Schönbrunn, Baozong Li, W. Guida, 2009, The Journal of Biological Chemistry.

ERK couples chronic survival of NK cells to constitutively activated Ras in lymphoproliferative disease of granular lymphocytes (LDGL)

Sheng Wei, S. Sebti, A. Hamilton, 2004, Oncogene.

Discovery of Marinopyrrole A (Maritoclax) as a Selective Mcl-1 Antagonist that Overcomes ABT-737 Resistance by Binding to and Targeting Mcl-1 for Proteasomal Degradation*

Yan Liu, Shen-Shu Sung, Rongshi Li, 2012, The Journal of Biological Chemistry.